Cite
MLA Citation
M. Farnier et al.. “Efficacy of alirocumab in heterozygous familial hypercholesterolemia or high cv risk populations: pooled analyses of eight phase 3 trials.” Atherosclerosis, vol. 241, no. 1, 2015, pp. e25–e26. http://access.bl.uk/ark:/81055/vdc_100050933325.0x00005f